Karisma Rh Collagen: What Is Injected and What to Expect
Has someone suggested Karisma Rh Collagen for firmer, better-hydrated looking skin, and you want to know what will actually be injected and how natural the result might look? KARISMA FACE Rh Collagen is an injectable medical device combining a recombinant type I collagen polypeptide, hyaluronic acid and carboxymethylcellulose. The manufacturer describes it as a soft “biorestorative” filler, not an ordinary serum or a universal substitute for volumising fillers. Possible changes in skin quality must be separated from promises to “restore your youth”: evidence does not justify such absolutes.
What is in the product, and why does it matter?
Manufacturer Taumedika identifies three ingredients. Rh Collagen is a recombinant polypeptide related to the α1 chain of type I collagen, made using transgenic silkworm biotechnology. It is not a solution of whole human collagen taken from human skin. High-molecular-weight hyaluronic acid binds water and affects the properties of the injectable material. Carboxymethylcellulose (CMC) affects the formulation’s consistency and behaviour in tissues. This is one multi-ingredient medical device, not three independent injections.
Advertising sometimes calls this “activation of your own collagen.” The claim draws on cell-laboratory work and published observations in humans. But a rise in laboratory biomarkers does not establish durable facial lifting for every person. Phrases such as “entirely safe,” “cannot cause allergy” or “guaranteed results” are particularly inappropriate for an injected material: hypersensitivity, inflammation and complications of injection remain possible.
Confirm the exact name KARISMA FACE Rh Collagen, the manufacturer and the current instructions for use (IFU). “Karisma collagen” in a message or price list does not authenticate the packaging, identify composition and indications, or establish lawful supply in a given country. The manufacturer calls it a Class III injectable medical device in the European context. That neither proves US FDA approval nor registration in Armenia. Request evidence that it can be legally supplied where your procedure would take place.
What outcome is realistic?
For fine surface lines, loss of smoothness or a dry appearance, a clinician may discuss Karisma among options for improving skin quality. Early fullness can reflect injected material, swelling and hydration. Later changes described as tissue remodelling need more time and separate assessment. Marked folds caused by facial proportions, significant loss of cheek volume or tissue descent are not necessarily solved by this treatment.
A 2024 observational study followed 100 participants receiving the product under a defined protocol involving two injection sessions with assessments at baseline, day 30 and day 60, without a randomised control group. Investigators described changes in measurements and patient-reported outcomes. This is preliminary support for possible benefit, not a personalised success rate, proof of effects lasting years or superiority over other injectables. Independent controlled comparisons and longer follow-up are needed. A study schedule must not become a mandatory prescription for everyone.
| Your goal | What to discuss with the clinician | Limit of Karisma |
|---|---|---|
| More even, less dry-looking skin | Reason for a gentle injectable approach and needle-free alternatives | Does not treat all causes of dryness and dermatitis |
| Fine lines and early loss of elasticity | Realistic size of improvement and when to evaluate it | No guaranteed removal of lines visible at rest |
| Insufficient cheek or chin volume | Whether another form of volumising is needed | Not the same as a firm contour filler |
| Significant sagging | Anatomical assessment and another strategy | Does not replace surgical lifting |
| Inflammation, suspicious mark or painful lump | Dermatological diagnosis first | Injection cannot treat an undiagnosed disease |
How is Karisma different from HA fillers and collagen stimulators?
The word “collagen” is not a useful basis for choosing. Firm, cross-linked hyaluronic-acid fillers are often designed to replace volume or contour the face. Karisma’s goal differs, even though it too contains hyaluronic acid. So-called collagen stimulators differ in active substance, injection depth, indications, restrictions and safety evidence. Research on one formulation is not evidence for another.
Another practical difference is how a result might be corrected. Hyaluronidase is sometimes used for certain hyaluronic-acid fillers, but Karisma contains several ingredients. It would be misleading to promise that this enzyme can simply and completely dissolve every unwanted effect. Management of lumps, asymmetry or complications depends on the exact composition and clinical findings; a clinician must decide. If predictable reversibility matters to you, discuss it before treatment.
It is reasonable to skip injections for now if appropriate skincare and sun protection can meet the main goal, if you cannot accommodate bruising, or if you have not been told what this particular product would improve. For the broader category see collagen biostimulators; individual photo comparisons belong on the Karisma before-and-after page.
Who should avoid or postpone treatment?
A publicly available KARISMA precaution document lists restrictions during pregnancy and breastfeeding, for those under 18, with sensitivity to ingredients, active infection or inflammation at the injection site, certain autoimmune connective-tissue and vascular collagen disorders, uncontrolled epilepsy and a tendency to hypertrophic scars. It prohibits intravascular injection and use outside stated indications. Verify all of this against the current official IFU for the specific product and country: a distributor document does not replace the authoritative instructions.
The available precautions also exclude injections in certain sites, including around the eyes and between the eyebrows, and warn about combinations with laser treatment, deep peels and dermabrasion. Someone else’s photographs of injections in those sites do not establish that they are allowed. If a clinician proposes an unusual location, ask to see the relevant current IFU and the rationale. Products promoted for similar goals can have different permitted treatment areas.
Report previous severe allergies, herpes, chronic illness, other fillers, cosmetic threads, surgery and recent dental or dermatological procedures. Anticoagulants and medicines affecting clotting can increase bruising. Never stop a prescription without speaking to its prescriber; postponement may be safer. An unexplained skin problem needs dermatological diagnosis rather than an injection intended to hide its symptoms.
What happens during injections, and how visible is recovery?
A responsible appointment begins with questions, not a syringe. The clinician establishes your aim, examines the tissues, screens for contraindications, explains the actual product and risks, and photographs only with consent. Anaesthesia, areas and injection technique must follow the current IFU and clinical judgment. You may feel needle pricks, pressure, brief burning or tenderness. “Completely painless” is not a promise; unusually severe pain should not be dismissed as normal.
Puncture marks, redness, local swelling, soreness or bruising may appear over the first hours and days. Some remain visible after normal activities resume. You may feel well enough to work while close-up photos still reveal where injections were given. For interviews, weddings or filming, leave a buffer rather than trusting “no marks tomorrow.” Individual bruising tendency and the extent of treatment influence recovery.
Do not rub or massage injection sites on your own initiative. An IFU may ask a clinician to distribute material immediately after injection; this is not permission for home massage. Ask for individual instructions about washing, makeup, exercise, pools, saunas, sun exposure and other procedures. One universal timeline will not fit every area and reaction. Keep the product name, batch number and the contact details of someone able to assess complications outside office hours.
Complications you must not overlook
Short-lived swelling, bruising and tenderness are different from complications. Infection, nodules or lumps, inflammatory reactions, persistent asymmetry and hypersensitivity are possible. Particularly serious concerns with filler-like injections are accidental entry into a blood vessel or impaired blood flow, which can damage skin; severe visual injury has been reported for filler injections in hazardous anatomical areas. The US FDA warns about these effects for the dermal-filler category. This does not establish their rate for Karisma or make its risk profile identical to other fillers, but it does justify a specific emergency-response plan.
Unusually severe or increasing pain, abruptly pale, grey or blue skin, a lacy change in colour, sudden vision disturbance, facial or arm weakness or difficulty speaking require immediate medical help. Do not wait for swelling to settle or try cosmetics as treatment. Fever, spreading redness, pus or increasing tenderness later also require prompt assessment. Before the procedure, learn how to reach the clinician and where to go if a routine follow-up is not available.
How to assess evidence, photos and product status
The brand emphasises resemblance to human collagen, comfort and naturalness. Those are manufacturer claims, not guarantees against immune reactions. A peer-reviewed publication adds information, but check for controls, longer follow-up, independent replication and surveillance for uncommon harms. Several striking before-and-after images cannot replace this; lighting, makeup, expression and swelling can all change their appearance.
Do not assume the manufacturer’s European device classification establishes local regulatory status in Armenia. Ask for the legal manufacturer, applicable instructions, proof of lawful supply, original sealed packaging, expiry date, batch number and clinician training. When given a price, check the amount of product, consultation, anaesthesia, review visit and management of complications included. A high price alone proves neither authenticity nor results.
Useful questions are specific: why does this formulation suit my concern more than skincare or another method; at what depth and in what approved site will it be injected; what might show over the first days; what counts as adequate improvement; how would lumps or vascular symptoms be managed; and what happens if I change my mind after the first visit? A clinician who answers calmly and allows postponement makes meaningful consent possible. That matters more than an appealing product name.
Frequently asked questions
Does Karisma stay in the body permanently?
The manufacturer describes it as resorbable. Advertising cannot tell you exactly how long individual components or effects will persist.
Is an allergy skin test mandatory beforehand?
There is no established universal test able to predict every reaction to this multi-component formulation. The clinician should review your history and the current IFU.
Can one syringe be shared by two people?
No. A sterile single-use product cannot be shared between patients or reused.